|1.||Tutel'ian, A V: 2 articles (09/2009 - 01/2009)|
|2.||Sinel'shchikova, O S: 2 articles (10/2003 - 06/2002)|
|3.||Torgovanova, G V: 2 articles (10/2003 - 06/2002)|
|4.||Riabtseva, O A: 1 article (01/2010)|
|5.||Trofimenko, S L: 1 article (01/2010)|
|6.||Volkov, A G: 1 article (01/2010)|
|7.||Bodzhokov, A R: 1 article (01/2010)|
|8.||Akimkin, V G: 1 article (09/2009)|
|9.||Salmina, T A: 1 article (09/2009)|
|10.||Kornilov, A B: 1 article (09/2009)|
10/01/2003 - "The aims were to study the effect of the preparation Imunofan, an immune stimulator, on various behavioral manifestations of pain reactions in animals with different individual resistances to stress and to compare the results with similar data in a natural model of immune activation. "
06/01/2002 - "The research problems included a study of influence of the immune stimulation with preparation "Imunofan" upon pain responses depending on individual resistance of animals to a stress, and the obtained results were compared with similar data in natural model of immune activation. "
10/01/2003 - "Intracerebroventricular administration of Imunofan was accompanied by more marked and complex changes in pain sensitivity."
|2.||Virus Diseases (Viral Diseases)
01/01/2009 - "To potentiate the effect of basic therapy and to correct of immune dysfunction in type 2 diabetes mellitus (T2DM) patients with diabetic foot syndrome by using the immunoregulatory peptide imunofan. "
01/01/2009 - "[Using regulatory peptide imunofan in type 2 diabetes mellitus patients with diabetic foot syndrome]."
|5.||Endometrial Neoplasms (Endometrial Cancer)